Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
The objective of this study was to investigate the properties of tablets containing granulations of ibuprofen (Ibu) and Ammonio Methacrylate Copolymer, Type B (Eudragit RS PO) prepared by hot-melt processing. Tablets were compressed from granules prepared by hot-melt granulation (HMG) or direct compression (DC). For the hot-melt extrusion (HME) process, tablets were prepared by cutting the extrudate, manually. The physicochemical properties of tablets were investigated using thermal analysis, powder X-ray diffraction analysis, tablet hardness, and drug dissolution. The effect of thermal treatment of tablets on the dissolution characteristics of Ibu was also investigated. The results demonstrated that the Ibu lowered the glass transition temperature (Tg) of the Eudragit RS PO and the softened polymer functioned as a thermal binder in the granulation. Ibu was demonstrated to be an effective plasticizer for Eudragit RS PO in the thermal processes. The efficiency of the granulation process increased with increasing levels of Eudragit RS PO in the powder blend. Higher levels of Eudragit RS PO in the tablets prepared by HMG or HME resulted in a decrease in the dissolution rate of the Ibu. An increase in the amount of Ibu in the tablets prepared by HMG or DC led to a decrease in the initial dissolution rate of the Ibu. Following the thermal treatment of the Ibu tablets prepared by HMG, the dissolution rate was significantly decreased due to structural changes in the tablets that resulted from the fusion and coalescence of plasticized polymer particles, causing a reduction in tablet porosity. The Ibu tablets prepared by HME demonstrated minimal changes in their release properties following thermal treatment even at temperatures higher than the Tg of the polymer. HME was shown to be a novel method to prepare matrix tablets and stable dissolution properties were obtained when tablets were stored at 40 degrees C for 30 days.
Kidokoro
M
M
College of Pharmacy, University of Texas at Austin, Austin, TX 78712, USA. kidokknl@daiichipharm.co.jp
Shah
N H
NH
Malick
A W
AW
Infeld
M H
MH
McGinity
J W
JW
D000180:Acrylic Resins / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D006358:Hot Temperature; D007052:Ibuprofen / Q000008:administration & dosage*; D010968:Plasticizers; D011208:Powders; D013607:Tablets; D013678:Technology, Pharmaceutical
D000180:Acrylic Resins; D000894:Anti-Inflammatory Agents, Non-Steroidal; D010968:Plasticizers; D011208:Powders; D013607:Tablets; C050528:Eudragit RS; D007052:Ibuprofen